Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
26.77
+0.44 (1.67%)
At close: Nov 25, 2025, 4:00 PM EST
26.50
-0.27 (-1.01%)
After-hours: Nov 25, 2025, 7:01 PM EST
Progyny Stock Forecast
Stock Price Forecast
The 8 analysts that cover Progyny stock have a consensus rating of "Buy" and an average price target of $27.25, which forecasts a 1.79% increase in the stock price over the next year. The lowest target is $25 and the highest is $30.
Price Target: $27.25 (+1.79%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Progyny stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 2 | 2 | 2 | 2 | 3 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $23 → $26 | Hold | Maintains | $23 → $26 | -2.88% | Nov 17, 2025 |
| Keybanc | Keybanc | Hold → Buy Upgrades $30 | Hold → Buy | Upgrades | $30 | +12.07% | Nov 12, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $25 → $26 | Hold | Maintains | $25 → $26 | -2.88% | Nov 11, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $23 → $25 | Hold | Maintains | $23 → $25 | -6.61% | Aug 26, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $21 → $23 | Hold | Maintains | $21 → $23 | -14.08% | Aug 20, 2025 |
Financial Forecast
Revenue This Year
1.28B
from 1.17B
Increased by 10.00%
Revenue Next Year
1.41B
from 1.28B
Increased by 9.42%
EPS This Year
0.63
from 0.57
Increased by 10.72%
EPS Next Year
1.03
from 0.63
Increased by 63.77%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.3B | 1.6B | |||
| Avg | 1.3B | 1.4B | |||
| Low | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.2% | 21.2% | |||
| Avg | 10.0% | 9.4% | |||
| Low | 3.8% | 2.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.74 | 1.98 | |||
| Avg | 0.63 | 1.03 | |||
| Low | 0.56 | 0.64 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 28.9% | 214.4% | |||
| Avg | 10.7% | 63.8% | |||
| Low | -2.0% | 0.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.